Kimia Farma Tbk PT
IDX:KAEF

Watchlist Manager
Kimia Farma Tbk PT Logo
Kimia Farma Tbk PT
IDX:KAEF
Watchlist
Price: 610 IDR Market Closed
Market Cap: 3.4T IDR
Have any thoughts about
Kimia Farma Tbk PT?
Write Note

Intrinsic Value

The intrinsic value of one KAEF stock under the Base Case scenario is 1 040.56 IDR. Compared to the current market price of 610 IDR, Kimia Farma Tbk PT is Undervalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KAEF Intrinsic Value
1 040.56 IDR
Undervaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Kimia Farma Tbk PT

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for KAEF cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about KAEF?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Kimia Farma Tbk PT

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Kimia Farma Tbk PT

Provide an overview of the primary business activities
of Kimia Farma Tbk PT.

What unique competitive advantages
does Kimia Farma Tbk PT hold over its rivals?

What risks and challenges
does Kimia Farma Tbk PT face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Kimia Farma Tbk PT.

Provide P/S
for Kimia Farma Tbk PT.

Provide P/E
for Kimia Farma Tbk PT.

Provide P/OCF
for Kimia Farma Tbk PT.

Provide P/FCFE
for Kimia Farma Tbk PT.

Provide P/B
for Kimia Farma Tbk PT.

Provide EV/S
for Kimia Farma Tbk PT.

Provide EV/GP
for Kimia Farma Tbk PT.

Provide EV/EBITDA
for Kimia Farma Tbk PT.

Provide EV/EBIT
for Kimia Farma Tbk PT.

Provide EV/OCF
for Kimia Farma Tbk PT.

Provide EV/FCFF
for Kimia Farma Tbk PT.

Provide EV/IC
for Kimia Farma Tbk PT.

Show me price targets
for Kimia Farma Tbk PT made by professional analysts.

What are the Revenue projections
for Kimia Farma Tbk PT?

How accurate were the past Revenue estimates
for Kimia Farma Tbk PT?

What are the Net Income projections
for Kimia Farma Tbk PT?

How accurate were the past Net Income estimates
for Kimia Farma Tbk PT?

What are the EPS projections
for Kimia Farma Tbk PT?

How accurate were the past EPS estimates
for Kimia Farma Tbk PT?

What are the EBIT projections
for Kimia Farma Tbk PT?

How accurate were the past EBIT estimates
for Kimia Farma Tbk PT?

Compare the revenue forecasts
for Kimia Farma Tbk PT with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Kimia Farma Tbk PT and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Kimia Farma Tbk PT against its competitors.

Analyze the profit margins
(gross, operating, and net) of Kimia Farma Tbk PT compared to its peers.

Compare the P/E ratios
of Kimia Farma Tbk PT against its peers.

Discuss the investment returns and shareholder value creation
comparing Kimia Farma Tbk PT with its peers.

Analyze the financial leverage
of Kimia Farma Tbk PT compared to its main competitors.

Show all profitability ratios
for Kimia Farma Tbk PT.

Provide ROE
for Kimia Farma Tbk PT.

Provide ROA
for Kimia Farma Tbk PT.

Provide ROIC
for Kimia Farma Tbk PT.

Provide ROCE
for Kimia Farma Tbk PT.

Provide Gross Margin
for Kimia Farma Tbk PT.

Provide Operating Margin
for Kimia Farma Tbk PT.

Provide Net Margin
for Kimia Farma Tbk PT.

Provide FCF Margin
for Kimia Farma Tbk PT.

Show all solvency ratios
for Kimia Farma Tbk PT.

Provide D/E Ratio
for Kimia Farma Tbk PT.

Provide D/A Ratio
for Kimia Farma Tbk PT.

Provide Interest Coverage Ratio
for Kimia Farma Tbk PT.

Provide Altman Z-Score Ratio
for Kimia Farma Tbk PT.

Provide Quick Ratio
for Kimia Farma Tbk PT.

Provide Current Ratio
for Kimia Farma Tbk PT.

Provide Cash Ratio
for Kimia Farma Tbk PT.

What is the historical Revenue growth
over the last 5 years for Kimia Farma Tbk PT?

What is the historical Net Income growth
over the last 5 years for Kimia Farma Tbk PT?

What is the current Free Cash Flow
of Kimia Farma Tbk PT?

Discuss the annual earnings per share (EPS)
trend over the past five years for Kimia Farma Tbk PT.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kimia Farma Tbk PT

Current Assets 5.3T
Cash & Short-Term Investments 505.1B
Receivables 2.3T
Other Current Assets 2.5T
Non-Current Assets 11.6T
Long-Term Investments 1.1T
PP&E 10.1T
Intangibles 168.9B
Other Non-Current Assets 228B
Current Liabilities 7.8T
Accounts Payable 1.7T
Accrued Liabilities 513.5B
Short-Term Debt 4.1T
Other Current Liabilities 1.5T
Non-Current Liabilities 3.7T
Long-Term Debt 2.4T
Other Non-Current Liabilities 1.3T
Efficiency

Earnings Waterfall
Kimia Farma Tbk PT

Revenue
10.1T IDR
Cost of Revenue
-7.7T IDR
Gross Profit
2.4T IDR
Operating Expenses
-4.5T IDR
Operating Income
-2.1T IDR
Other Expenses
371.7B IDR
Net Income
-1.7T IDR

Free Cash Flow Analysis
Kimia Farma Tbk PT

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

KAEF Profitability Score
Profitability Due Diligence

Kimia Farma Tbk PT's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative 1-Year Revenue Growth
Negative 3-Years Revenue Growth
Declining ROIC
29/100
Profitability
Score

Kimia Farma Tbk PT's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

KAEF Solvency Score
Solvency Due Diligence

Kimia Farma Tbk PT's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average D/E
Short-Term Solvency
Positive Net Debt
28/100
Solvency
Score

Kimia Farma Tbk PT's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KAEF Price Targets Summary
Kimia Farma Tbk PT

There are no price targets for KAEF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for KAEF?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for KAEF is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Kimia Farma Tbk PT Logo
Kimia Farma Tbk PT

Country

Indonesia

Industry

Pharmaceuticals

Market Cap

3.4T IDR

Dividend Yield

0%

Description

PT Kimia Farma Tbk engages in the production and distribution of healthcare products. The company is headquartered in Jakarta, Dki Jakarta and currently employs 11,668 full-time employees. The company went IPO on 2001-07-04. The firm produces medical devices and chemical materials. The firm is also involved in producing vegetable oil, iodine, and salts. Its products include Glucokaf, Diazink, Oracef, Kifarox, Magacid Suspension, Magaside Chewable Tablets, Nitrocafe Retarded, Nitrocafe Retard Forte, Trinolon, Raistine, VAGIZOL, Neviral, Hiviral Tablet, Duviral, Codipront Cum Expectorant, RETHAPHYL SR, and SUPRAFLU. Its generic products include PETHIDIN Hcl, PARACETAMOL, Diclofenac Sodium, MEPHANAMIC ACID, ANTALGIN, ANTASIDE DOEN, PYRANTEL, ALBENDAZOLE, METRONIDAZOLE TABLET, NEO BLOOD ADDING TABLET, FERROUS SULOATE SYRUP, DIMENHYDRINATE, ACYCLOVIR, AMBROXOL HCL, CHLOROQUINE, CHLORPROMAZINE HCL, CODEIN, CLOPIDOGREL, ERGOTAMINE COFFEE, METHYLERGOMETRINE TABLET SALUTE, MELOXICAM, and Pherphenazine.

Contact

DKI JAKARTA
Jakarta
Jalan Veteran No. 9
+62213847709
www.kimiafarma.co.id

IPO

2001-07-04

Employees

11 668

Officers

President Director
Mr. David Utama
Finance & Risk Management Director and Director
Engineer Lina Sari M.M.
Compliance & Risk Management Unit Manager
Ms. - Rosrini
General Manager of Marketing & Sales
Ms. Eva Fairus
Marketing, Research and Development Director & Director
Ms. Jasmine K. Karsono Ph.D.
Human Resources Director & Director
Mr. Dharma Syahputra M.M.
Show More
Head of Internal Audit
Budi Her Utomo CIA, CPIA, M.M.
Commercial Director & Director
Ms. Chairani Harahap S.E.
Production & Supply Chain and Director & Director
Mr. Hadi Kardoko
General Manager of Corporate Secretary
Mr. Ganti Winarno Putro
Show Less

See Also

Discover More
What is the Intrinsic Value of one KAEF stock?

The intrinsic value of one KAEF stock under the Base Case scenario is 1 040.56 IDR.

Is KAEF stock undervalued or overvalued?

Compared to the current market price of 610 IDR, Kimia Farma Tbk PT is Undervalued by 41%.

Back to Top